The tumor size at 19 days of the nude mice in situ implanted by CD133++DP-CLPs-PTX-survivin siRNA were much more significantly decreased compared with the group of CD133++PTX, CD133++CLPs-PTX-survivin siRNA and the control. This evidence concerns the gene PROM1 and neoplasm.